BUHLMANN Quantum Blue Adalimumab Archives - Buhlmann Diagnostics Corp

Tag: BUHLMANN Quantum Blue Adalimumab

BUHLMANN Quantum Blue® TDM Tutorial

View this demonstration of quantitative trough level measurement for TDM using the Quantum Blue® TDM rapid test technology.   Quantum Blue® Adalimumab:  Health Canada License: 101776 Quantum Blue® Infliximab: Health Canada License: 98838 US: (The Quantum Blue® tests are for Research Use Only. Not for use in diagnostic procedures.) Contact BUHLMANN Today! Contact us &
Continue Reading

Connect with BUHLMANN at CDDW 2019!

Canadian Digestive Diseases Week (CDDW) 2019 BUHLMANN Diagnostics Corp Booth: #116 Mar 1 - 3, 2019 | Fairmont Banff Springs Hotel | Banff Alberta Learn More Visit our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio: IBDoc®, the ONLY in-vitro diagnostic POC and home testing device to measure the inflammatory marker, fecal
Continue Reading

LabSense News Fall 2018 Edition

Continue Reading

BUHLMANN – LabSense News Spring 2018 Edition

In this “Summer Edition” we are pleased to share the launch of the of Quantum Blue® Adalimumab assay as well as announce some recent enhancements to the Quantum Blue® Infliximab assay. We also make mention of the upcoming meetings…

Continue Reading